Form 4: Cargo Therapeutics Officer Acquires Restricted Stock Units

Anup Radhakrishnan, Interim CEO, CFO, and COO of Cargo Therapeutics, acquired 72,500 restricted stock units (RSUs) on May 12, 2025, under a retention program.

Summary

• Anup Radhakrishnan, Interim Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer of Cargo Therapeutics, acquired 72,500 shares of Common Stock in the form of Restricted Stock Units (RSUs) on May 12, 2025.
• These RSUs vest 100% on the grant date and were granted pursuant to a retention program.
• Following the transaction, Radhakrishnan directly owns 149,817 shares of Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing related to stock options. The retention program suggests a positive intent to retain key personnel.

Positives

• The grant of RSUs to a key officer like Radhakrishnan suggests an effort to retain him, which can be seen as a positive signal.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's prospects.

Stakeholder Impact

• The acquisition of RSUs by a key officer could reassure shareholders about the company's commitment to retaining its leadership.

Key Dates

Keywords

Cargo Therapeutics, CRGX, Anup Radhakrishnan, Restricted Stock Units, RSUs, Retention Program, Form 4, Beneficial Ownership, Officer, Common Stock